Hyaluronic Acid in Belo Horizonte BR
Injectable fillers are one of the most popular facial rejuvenation techniques. As we age, the underlying tissues that keep our skin looking youthful and firm begin to break down due to the effects of gravity, sun exposure, diet, genetic factors, and years of facial muscle movement. Over time these factors contribute to the development of lines, wrinkles, and folds in the face.
Your skin consists of two layers known as the epidermis and the dermis. The epidermis, or outer layer of the skin, acts as the skin’s primary defense against the environment. The dermis, or innermost layer of the skin, is composed primarily of connective tissue and provides the skin with a support network. Most facial wrinkles and deeper folds occur within the dermal layer of the skin.
Within the connective tissue of the dermis, collagen and elastin fibers form a network that provides the skin with structure, support, and elasticity. Furthermore, fat cells and other molecules, such as hyaluronic acid, help to create volume beneath facial skin. With time, this network of collagen and elastin fibers breaks down, and hyaluronic acid molecules and fat cells that create volume are depleted. Together breakdown and depletion of these molecules result in wrinkles and other changes to facial skin.
When used as standalone treatments or with other procedures, injectable fillers can reduce or eliminate wrinkles and scars, create fuller lips, and treat lipoatrophy, or fat loss beneath the skin. With little downtime and almost immediate results, injectable fillers offer a safe, effective method of restoring a smoother, more youthful appearance.
Hyaluronic acid is a naturally occurring complex sugar molecule that forms large matrices in the connective tissue of the body, such as skin and cartilage. Much like a sponge, its primary function is to bind and absorb water molecules, which creates volume in the face. Hyaluronic acid fillers are generally used to treat facial wrinkles and folds and to enhance the appearance of the lips. One of the fastest growing dermal filler treatments available, hyaluronic acid fillers work by replacing the hyaluronic acid in the body that has depleted over time, which restores the volume beneath the skin’s surface.
While there are a variety of hyaluronic acid fillers, some of the most common are Hylaform®, Restylane®, and Juvederm®. Hylaform®, marketed by INAMED Aesthetics, consists of avian, or bird-derived, hyaluronic acid. Restylane®, marketed by Medicis, and Juvederm®, marketed by Allergan, are both non-animal derived forms of hyaluronic acid produced in the laboratory. Hyaluronic acid fillers are generally biocompatible, which means allergy skin testing is not required prior to treatment.
Depending on the extent of treatment, hyaluronic acid injection procedures typically last between fifteen and sixty minutes. Prior to the start of your procedure, the treatment areas will be cleansed, usually using an alcohol based cleaner. Unlike collagen injections, hyaluronic acid injections do not include an anesthetic agent. Therefore, a local or topical anesthetic may be used to numb the treatment area during the procedure.
Using an ultra fine needle, hyaluronic acid is injected into the dermis at several points along the edge of the treatment area. After approximately two to three injections, the physician will massage the treatment area. The physician will continue injecting the filler along the length of the wrinkle or fold until maximum correction has been achieved. If a local anesthesia has not been used, you may feel some minor stinging from the injections. As the injected hyaluronic acid molecules attract and bind water molecules, the volume beneath the skin will increase, restoring a smoother, more youthful appearance.
Immediately following the injections, you may experience some redness, slight stinging, minor swelling, or bruising in the treatment area. Tiny scabs may also form at the injection sites. These symptoms typically disappear within two to three days. No bandaging is necessary and most patients are able to resume normal activities immediately.
The body will eventually metabolize and absorb the injected hyaluronic acid over time. Therefore, while the effects are immediate, hyaluronic acid injections do not provide the same long-lasting results that may be gained from cosmetic surgery. Although the longevity of results varies by patient, results from hyaluronic acid injections are typically maintained for six to twelve months.
More Belo Horizonte info...
Belo Horizonte By plane
BH is served by two airports:
Confins (Aeroporto Internacional Tancredo Neves) - Rodovia MG 010 S/N, 40 km - Confins/MG. Phone: (31) 3689-2700. The majority of flight now go here with seemingly less and less flights landing at Pampula. Receives a few international flights and most domestic flights. It's located about 40 km from the city center. It is connected to the downtown area by Conex?o Aeroporto express buses (R$ 12) and taxis.
Pampulha (Aeroporto Carlos Drummond de Andrade). For some domestic flights, especially within the state of Minas Gerais. 9 km from the city center . -
Belo Horizonte Mid-range
Le Flamboyant - Rua Rio Grande do Norte, 1007. Phone (31) 3261-5233 (fax (31) 3261-7370)[2]. Good value for money. The 80s d?cor may be a little out of date, but the flats are spacious and there is a swimming pool for guests. Besides, location is excellent: right in the middle of the lively Savassi neighborhood. Singles/doubles R$ 100-120. -
Plastic Surgery News...
- Three-year results reported from a controlled trial of etanercept plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) confirm the continued efficacy of the combination against monotherapy, with no unexpected adverse effects.
The TEMPO trial was planned from outset as a longer-term, three-year study. It compared etanercept plus MTX against either drug as monotherapy in adult patients with active RA not responding to at least one previous DMARD other than MTX. They were randomised to double-blind treatment with etanercept, MTX, or the combination; initial outcomes focussed on response to treatment using ACR criteria. For the long-term phase, the outcomes used were disease activity and remission using the Disease Activity Score (DAS); response according the ACR score was also assessed. The authors used statistical techniques that attempted to correct for biases inherent in long-term therapeutic trials.
TEMPO initially randomised 686 patients, of whom 682 received at least one dose of study drug. Over the three years, 350 patients withdrew from the trial, with more withdrawals due to inefficacy in the monotherapy groups (combination group 5% vs. 16% for etanercept and 17% for MTX). Analysis indicated that those in the combination therapy group had greater improvement in DAS and were more likely to remain in remission than those in either monotherapy group. Patients in the combination group did better than those in the monotherapy groups on most other outcomes; the combination and etanercept were both better than MTX alone for radiographic progression. Adverse effects were similar across the three groups, and no new or unexpected adverse effects were reported in year three.
Overall, the authors conclude that etanercept plus MTX combination treatment continued to show superior efficacy to monotherapy over three years, even after adjustment for withdrawals. There were no additional safety concerns.
- The Vatican on Friday responded to last week's report that U.S. researchers had cloned five human embryos by calling this type of cloning the "worst type of exploitation of the human being," Reuters Health reports.Monsignor Elio Sgreccia, president of the Pontifical Academy for Life, said the cloning of human embryos "ranks among the most morally illicit acts, ethically speaking.